ARTICLE | Company News
CeNeRx, Krenitsky Pharmaceuticals deal
June 22, 2009 7:00 AM UTC
CeNeRx received exclusive, worldwide rights from Krenitsky to develop and commercialize CXB909 to treat and prevent neuropathies and neurodegenerative disorders. The oral small molecule that enhances...